City

Scottsdale (2)

Bologna (1)

Gravedona (1)

Condition

Pancreas Metastases (4)

Pancreas Cancer (2)

Pancreatic Adenocarcinoma (2)

Pancreatic Cancer (2)

Pancreatic Ductal Adenocarcinoma (2)

Adenocarcinoma (1)

Colorectal Cancer (1)

Pancreatic Adenocarcinoma Resectable (1)

Overall Status

Completed (2)

Active, not recruiting (1)

Recruiting (1)

Phase

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

HonorHealth Research Institute (2)

Ospedale Generale Di Zona Moriggia-Pelascini (1)

University of Bologna (1)

Intervention

ascorbic acid (1)

cisplatin (1)

endoscopic ultrasound-guided fine needle biopsy (1)

gemcitabine (1)

paclitaxel protein-bound (1)

pancreas surgery (1)

paricalcitol (zemplar) (1)

Study Documents

Intervention Type

drug (2)

diagnostic test (1)

procedure (1)

Funder Type

Other (4)

Study Type

Interventional (2)

Observational (2)

pancreas metastases

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Pancreas Resection for Colorectal Metastasis: Retrospective

Recruiting

Pancreas Metastases
Colorectal Cancer

Pancreas surgery

Gravedona, Como, Italy

Ospedale Generale di zona Moriggia Pelascini

Feb 5, 2023

Repeated EUS-guided Fine Needle Biopsy of Pancreatic Masses

Completed

Pancreatic Adenocarcinoma
+2 more

endoscopic ultrasound-guided fine needle biopsy

Bologna, Italy

Gastrointestinal Unit, University of Bologna/Hospital of Imola

Nov 7, 2022

Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Pancreatic Adenocarcinoma Trial in Scottsdale (Paricalcitol (Zemplar))

Active, not recruiting

Pancreatic Cancer
+4 more

Paricalcitol (Zemplar)

Scottsdale, Arizona

HonorHealth Research Institute

Feb 16, 2022

Pancreatic Cancer, Pancreas Cancer, Pancreatic Adenocarcinoma Resectable Trial in Scottsdale (Ascorbic Acid, Paclitaxel

Completed

Pancreatic Cancer
+4 more

Ascorbic Acid
+3 more

Scottsdale, Arizona

HonorHealth Research Institute

Feb 10, 2022